MEDIPRINT OPHTHALMICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Mar 2024)
What this means for you
This application is over — abandoned 11 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90755523
- Mark type
- Design + words
- Filed
- 04 Jun 2021
- Published for opposition
- 14 Jun 2022
- Abandoned
- 11 Mar 2024
- Attorney of record
- Glenn E. Davis
Goods and services
- Class 005 — Pharmaceuticals: Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
Owner
- MediPrint Ophthalmics, Inc., San Diego, CA, US
- MediPrint Ophthalmics, Inc., San Diego, CA, US
Prosecution history
- 11 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2023 — SOU EXTENSION 2 GRANTED
- 31 Jul 2023 — SOU EXTENSION 2 FILED
- 31 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2023 — SOU EXTENSION 1 GRANTED
- 09 Feb 2023 — SOU EXTENSION 1 FILED
- 09 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jun 2022 — PUBLISHED FOR OPPOSITION
- 25 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED